Found 5 matching trials
Phase 1/2a Study of JAB-21822 Plus JAB-3312 in Patients With Advanced Solid Tumors Harboring KRAS p.G12C Mutation
PHASE1This is a multicenter, open-label phase 1/2a study consisting of two parts:...
Location
The First Affiliated Hospital of USTC Anhui Provincial Hospital
A Study of JAB-3312 in Adult Patients With Advanced Solid Tumors in China
PHASE1This is a Phase 1, open-label dose-escalation study to determine the maximu...
Location
Cancer Hospital, Chinese Academy of Medical Sciences
JAB-3312 Based Combination Therapy in Adult Patients With Advanced Solid Tumors
PHASE1To evaluate the safety and tolerability of JAB-3312 administered in investi...
JAB-21822 Combined With JAB-3312 Compared SOC in the First Line for Treatment of Advanced Non-small Cell Lung Cancer With KRAS p.G12C Mutation
PHASE3This Phase 3 study will evaluate the efficacy of JAB-21822+JAB-3312 versus ...
Location
Anhui Province cancer hospital
A First-in-Human, Phase 1 Study of JAB-3312 in Adult Patients With Advanced Solid Tumors
PHASE1This is a Phase 1, first-in-human, open-label dose-escalation study to dete...
Location
HealthONE Clinic Services Oncology-Hematology